Close on 16 Oct 2026
All Indian Equities

SAROJA PHARMA INDUS IND L

SAROJA-SMVerified
ISIN: INESAROJA01010 · Exchange: NSE

SAROJA PHARMA INDUS IND L is a publicly traded security listed on the NSE exchange.

Sector: Diversified Indian Equities·Industry: Public Market Listed Security·Market Cap: LARGE CAP
Close on 19 Oct 2026
₹40.80
+0.00 (+0.00%)
Last updated: 19 Oct 2026 (NSE/BSE EOD settlement)

Stock Snapshot & Key Numbers — SAROJA PHARMA INDUS IND L

Verified Daily Close

Official closing price, 1-year price range, valuation multiples, and market value from exchange records.

Last Session Move
Up +0.00% on 19 Oct 2026
Position vs 1-Year High
Near 52-Week High
P/E Valuation Multiple
Not Reported / Loss
Annual Cash Dividend
0.00% / No Recent Dividend
Close on 19 Oct 2026
₹40.80
+0.00 (+0.00%)vs prev close
1-Year Low to High Range50% of range
Low: ₹41High: ₹41
Valuation (P/E, P/B & Dividend)
P/E Ratio (Price / Profit):N/A
P/B Ratio (Price / Book):N/A
Dividend Yield:0.00%
Total Company Value (Market Cap)
—
Sector: Diversified Indian Equities
Plain-English Company Summary

SAROJA PHARMA INDUS IND L (SAROJA-SM) is a Indian equity security listed on the NSE with ISIN INESAROJA01010. As of the last recorded market session on Close on 19 Oct 2026, the stock closed at ₹40.80, recording a +0.00 (+0.00%) advance from its previous close of ₹40.80. Over the trailing 52-week trading cycle, SAROJA-SM has traded between a 52-week low of ₹40.80 and a 52-week high of ₹40.80, establishing its annual trading channel. In historical performance, SAROJA PHARMA INDUS IND L has gained 0% over the past 1 year. Period returns across standard measurement intervals include: 1-month: +0%, 6-month: +0%, 1-year: +0%, 3-year: +0%, 5-year: +0%. Daily reported trading volume reached 1,600 equity shares. On key valuation multiples as of 25 Oct 2026, the company trades at a trailing price-to-earnings (P/E) multiple of data unavailable and a price-to-book (P/B) ratio of data unavailable, with a trailing dividend yield of 0.00%. Its market capitalization stands at —. The company is categorized under the Diversified Indian Equities sector and Public Market Listed Security industry within the Indian equities universe.

Price Chart

1Y: +0.00% (₹0.00)
₹41₹41₹41₹41Wed, 30 Sept, 2026Mon, 19 Oct, 2026

Trading Multiples & Ranges

Price boundaries and liquidity distribution.

52-Week Channel₹40.80
Low: ₹40.8High: ₹40.8
Day Range₹40.8 – ₹40.8
Market Cap—
Reported Volume1,600
P/E Ratio (TTM)—
Price-to-Book (P/B)—
Dividend Yield0.00%
Fundamentals as of 25 Oct 2026

Trailing Returns Breakdown

Calendar-aligned historical percentage performance across standard market windows.

PeriodStart PriceCurrent PriceReturn (%)
1 Month₹40.80₹40.80+0.00%
3 Months₹40.80₹40.80+0.00%
6 Months₹40.80₹40.80+0.00%
1 Year₹40.80₹40.80+0.00%
3 Years₹40.80₹40.80+0.00%
5 Years₹40.80₹40.80+0.00%

Price Swings & Biggest Historical Drops

How much this stock typically fluctuates and its largest peak-to-bottom drops over 1 and 5 years.

1Y Yearly Swing
—
Annualized volatility
1Y Beta vs Index
—
vs benchmark index
Biggest 1Y Drop
0.0%
1Y peak-to-low drop
Biggest 5Y Drop
0.0%
5Y peak-to-low drop
vs 52W High
0.0%
Distance from 1Y high
vs 52W Low
+0.0%
Gain above 1Y low

Calendar-Year Historical Performance

Annual performance breakdown comparing first and last closing sessions of each calendar year.

Calendar YearStart CloseEnd CloseAnnual ReturnTrajectory Bar
CY 2026₹40.80₹40.80+0.0%

Historical Investment Simulator

Factual simulation of past returns in SAROJA PHARMA INDUS IND L (SAROJA-SM) using real recorded closing prices.

$10,000.00
5 Years
Principal Invested
$10,000.00
$10,000 initial capital
Portfolio Value Today
$10,113.00
Based on latest close
Absolute Return
+1.1%
+$113.00
Annualized (CAGR)
+24.1%
Annualized compound growth
Entry Price: $0.42 · Exit Price: $0.43
Simulated 5Y period (USD)

Corporate Actions History

No dividend or stock split distributions recorded in historical feeds for SAROJA-SM.

No material filings, mega-tenders, or wire events detected in trailing 6-month observation window.

Why This Matters for the Business

Plain-English breakdown of how the selected announcement connects to revenue, costs, and business drivers.

Earnings & Operational Baseline

SAROJA PHARMA INDUS IND L trades at ₹40.80 within its 52-week band of ₹41 – ₹41. With fundamental momentum characterized as NEUTRAL, valuation is anchored by core cash generation in diversified indian equities segments.

Cross-asset macro betas (Brent Crude, USD/INR, NIFTY) are mapped in the dedicated dependency engine.
View Graph
Evidence Integrity: Hypotheses and attribution models are anchored strictly in verified regulatory disclosures, public tenders, and audited financial statements across a trailing 6-month capital cycle.

At-a-Glance Health & Momentum Check

Market Mood: Consolidation / Rangebound
News Activity
DECELERATING
Recent announcement pace
Profit & Margin Trend
NEUTRAL
Earnings & margin direction
Economy Sensitivity
MODERATE
Impact of rates, oil & FX
Broad Market Mood
Consolidation / Rangebound
Current market trend
News Tone
NEUTRAL BALANCED
Recent filing tone
What This Means(based on reported financials)

Company filings and balance-sheet numbers show steady day-to-day operations with stable margins and working capital.

Active Risk Flags & Monitoring Constraints
Price testing 52-week support threshold with elevated trading volume

Peer & Sector Comparison — Next Research Steps

Exit points and comparative equity universe: same-sector peers, shared macro sensitivity betas, and your watchlist.

Explore All Equities
Same-Sector Peers
Diversified Indian Equities
No direct peers in sector coverage.
Same-Industry Peers
Industry Sub-Segment
No peer equities in this industry.
Also Viewed In Session
Recent History
Start browsing to build your active session footprint.

Common Questions About SAROJA PHARMA INDUS IND L (SAROJA-SM)

Key facts on SAROJA-SM share price, historical returns, valuation ratios, and past SIP performance.

What is the current share price and 52-week range of SAROJA PHARMA INDUS IND L (SAROJA-SM)?

As of 19 Oct 2026, the official closing share price of SAROJA PHARMA INDUS IND L (SAROJA-SM) on NSE is ₹40.80 (+0.00% vs the previous close). Over the past 52 weeks, SAROJA-SM has traded between a low of ₹40.80 and a high of ₹40.80, with a reported market capitalization of —.

What are the historical returns of SAROJA PHARMA INDUS IND L (SAROJA-SM)?

Based on split-adjusted closing prices through 19 Oct 2026, SAROJA PHARMA INDUS IND L (SAROJA-SM) recorded the following trailing price returns: 1 Month: +0.00% (from ₹40.80 to ₹40.80); 3 Months: +0.00% (from ₹40.80 to ₹40.80); 6 Months: +0.00% (from ₹40.80 to ₹40.80); 1 Year: +0.00% (from ₹40.80 to ₹40.80); 3 Years: +0.00% (from ₹40.80 to ₹40.80); 5 Years: +0.00% (from ₹40.80 to ₹40.80). Past performance reflects historical exchange records and does not predict future returns.

What is the P/E ratio, P/B ratio, and dividend yield of SAROJA PHARMA INDUS IND L (SAROJA-SM)?

SAROJA PHARMA INDUS IND L (SAROJA-SM) currently trades at a trailing Price-to-Earnings (P/E) ratio of not applicable (or negative trailing earnings), a Price-to-Book (P/B) ratio of not reported, and a trailing 12-month dividend yield of 0.00%. It operates in the Diversified Indian Equities sector (Public Market Listed Security).

How much would a past lump-sum or monthly SIP investment in SAROJA-SM have grown?

Based on historical closing prices for SAROJA PHARMA INDUS IND L (SAROJA-SM): A one-time lump-sum investment of ₹1,00,000.00 held for 5 years would be worth ₹1,00,000.00 (+0.0% total return, 0.0% CAGR), while a monthly SIP of ₹10,000.00 over 5 years (total invested: ₹20,000.00) would be worth ₹20,000.00 (+0.0% absolute return). You can test custom amounts and holding periods in the interactive calculator above.